the aid library

LIST OPTIONS

Filter

3596

Situation Analysis of Children with Disabilities in Myanmar

UNICEF Myanmar (2016)

The study analyses the current situation of children with disabilities in relation to realizing their rights and accessing basic services, as well as their life experiences in their communities. It also focuses on identifying the barriers created by society that prevent children with disabilities fr... more

Download (686)

View PDF (1676)

A new approach to cholera in Haiti: Report by the Secretary-General (A/71/895)

UN General Assembly (2017) C1

On 19 August 2016, the former UN Secretary-General announced a new approach to cholera in Haiti, consisting of two tracks. Track 1 focuses on reducing cholera transmission, improving access to care, and addressing water, sanitation, and health system issues. Track 2 aims to provide material assistan... more

Download (203)

View PDF (347)

COVID-19 Guidance Note: Virtual Inclusive Dialogue

Reliefweb; OCHA Services; The Global Fund (2020) C2

Date issued: 14 April 2020 The Global Fund is committed to ensuring that input from those closest to and living with HIV, tuberculosis and malaria are included in every funding request to the Global Fund. Their input is critical to ensuring that programs are effective and designed to help those m... more

Download (209)

View PDF (385)

The sociodemographic impacts of the COVID-19 pandemic in Latin America and the Caribbean

United Nations ECLAC (2022) C1

Latin America and the Caribbean is characterized by a matrix of social inequality whose axes —such as socioeconomic stratum, gender, stage in the life cycle, ethnicity and race, territory, disability, and immigration status— create multiple, often concurrent, situations of exclusion and discri... more

Download (320)

View PDF (318)

How COVID-19 is changing the world. Vol.III

UN Department of Economic and Social Affairs (2021) C1

Since the release of the first volume in May 2020, the COVID-19 pandemic has continued to rage around the world. By mid-March, 2021, countries around the globe had reported over 123 million cases—a nearly five-fold increase since this report’s previous volume—and over 2.7 million deaths attrib... more

Download (194)

View PDF (323)

Cardiovascular Diseases in Sub-Saharan Africa Compared to High-Income Countries: An Epidemiological Perspective

Yuyun, M.F.; Sliwa, K.; Kengne, A.P. et al. Global Heart (2020) CC

Non-communicable diseases (NCDs) are the second common cause of death in sub-Saharan Africa (SSA) accounting for about 35% of all deaths, after a composite of communicable, maternal, neonatal, and nutritional diseases. Despite prior perception of low NCDs mortality rates, current evidence suggests t... more

Download (265)

View PDF (238)

Polio Vaccine Security Framework

Global Polio Eradication Initiative GPEI (2025) CC

Long-term polio vaccine security – the timely, sustained, and uninterrupted supply of suitable types of affordable, quality-assured polio vaccines – is essential in the global effort to achieve and maintain a polio free world. However, fragmented approaches and short-term planning pose considera... more

External Link

External Link (211)

Chinese health funding in Africa: The untold story

Dolan C.B., Malik A.A., Zhang S., et al. PLOS Global Public Health (2023) CC

The motivations behind China’s allocation of health aid to Africa remain complex due to limited information on the details of health aid project activities. Insufficient knowledge about the purpose of China’s health aid hinders our understanding of China’s comprehensive role in supporting Afri... more

External Link

External Link (230)

Ambitions and realities: Are Global Fund investments designed to achieve resilient and sustainable systems for health?

Salisbury N., Nawaz S., Abenaitwe J., et al. PLOS Global Public Health (2024) CC

Strengthening resilient and sustainable systems for health (RSSH) is central to the Global Fund’s strategy, however questions persist about the Global Fund’s role in the health systems strengthening space, and the extent to which investments are designed to achieve strengthening objectives, or j... more

External Link

External Link (482)

Catastrophic health expenditure during the COVID-19 pandemic in five countries: a time-series analysis

Haakenstad A., Bintz C., Knight M., et al. Lancet Global Health (2023) CC

The COVID-19 pandemic disrupted health systems in 2020, but it is unclear how financial hardship due to out-of-pocket (OOP) health-care costs was affected. We analysed catastrophic health expenditure (CHE) in 2020 in five countries with available household expenditure data: Belarus, Mexico, Peru, R... more

External Link

Comparing priority received by global health issues: a measurement framework applied to tuberculosis, malaria, diarrhoeal diseases and dengue fever

Parashar R., Nanda S., Smith S.L., et al. BMJ Global Health (2024) CC

The relative priority received by issues in global health agendas is subjected to impressionistic claims in the absence of objective methods of assessment of priority. To build an approach for conducting structured assessments of comparative priority health issues receive, we expand the public ... more

External Link

External Link (501)

Germany’s role in global health at a critical juncture

Franz C., Holzscheiter A., Kickbusch I., et al. Lancet (2024) CC

When we presented our analysis of Germany’s role in global health in 2017 at an event in Berlin, Richard Horton, the Editor-in-Chief of The Lancet, asked only half-jokingly whether we could expect Germany to finally shrug off the habitus of the “reluctant leader” and “step up”. Back t... more

External Link

External Link (208)

Estimates of aid for reproductive, maternal, newborn, and child health: findings from application of the Muskoka2 method, 2002–17

Dingle, A.; Schäferhoff, M.; Borghi, J. et al. The Lancet (2020) CC

Background Four methods have previously been used to track aid for reproductive, maternal, newborn, and child health (RMNCH). At a meeting of donors and stakeholders in May, 2018, a single, agreed method was requested to produce accurate, predictable, transparent, and up-to-date estimates that coul...d be used for analyses from both donor and recipient perspectives. Muskoka2 was developed to meet these needs. We describe Muskoka2 and present estimates of levels and trends in aid for RMNCH in 2002–17, with a focus on the latest estimates for 2017. Methods Muskoka2 is an automated algorithm that generates disaggregated estimates of aid for reproductive health, maternal and newborn health, and child health at the global, donor, and recipient-country levels. We applied Muskoka2 to the Organisation for Economic Co-operation and Development's Creditor Reporting System (CRS) aid activities database to generate estimates of RMNCH disbursements in 2002–17. The percentage of disbursements that benefit RMNCH was determined using CRS purpose codes for all donors except Gavi, the Vaccine Alliance; the UN Population Fund; and UNICEF; for which fixed percentages of aid were considered to benefit RMNCH. We analysed funding by donor for the 20 largest donors, by recipient-country income group, and by recipient for the 16 countries with the greatest RMNCH need, defined as the countries with the worst levels in 2015 on each of seven health indicators. Findings After 3 years of stagnation, reported aid for RMNCH reached $15·9 billion in 2017, the highest amount ever reported. Among donors reporting in both 2016 and 2017, aid increased by 10% ($1·4 billion) to $15·4 billion between 2016 and 2017. Child health received almost half of RMNCH disbursements in 2017 (46%, $7·4 billion), followed by reproductive health (34%, $5·4 billion), and maternal and newborn health (19%, $3·1 billion). The USA ($5·8 billion) and the UK ($1·6 billion) were the largest bilateral donors, disbursing 46% of all RMNCH funding in 2017 (including shares of their core contributions to multilaterals). The Global Fund and Gavi were the largest multilateral donors, disbursing $1·7 billion and $1·5 billion, respectively, for RMNCH from their core budgets. The proportion of aid for RMNCH received by low-income countries increased from 31% in 2002 to 52% in 2017. Nigeria received 7% ($1·1 billion) of all aid for RMNCH in 2017, followed by Ethiopia (6%, $876 million), Kenya (5%, $754 million), and Tanzania (5%, $751 million). Interpretation Muskoka2 retains the speed, transparency, and donor buy-in of the G8's previous Muskoka approach and incorporates eight innovations to improve precision. Although aid for RMNCH increased in 2017, low-income and middle-income countries still experience substantial funding gaps and threats to future funding. Maternal and newborn health receives considerably less funding than reproductive health or child health, which is a persistent issue requiring urgent attention. Funding Bill & Melinda Gates Foundation; Partnership for Maternal, Newborn & Child Health. more

Download (251)

View PDF (480)

Health for all: transforming economies to deliver what matters: final report of the WHO Council on the Economics of Health for All: executive summary

World Health Organisation (WHO) (2024) C_WHO

As of May 2023, COVID-19 may no longer be classified as a public health emergency of international concern, but we must not ignore the deep structural problems it has revealed in our economy.

External Link

External Link (447)

Financialisation: a 21st century commercial determinant of health equity

Friel S., Schram A., Frank N., et al. Lancet Public Health (2024) CC

In 21st century capitalism, financial markets reign supreme. The elevation of investing, trading, and speculating as a way of making profit has shifted economic power towards institutional investors and enhanced the power of financial capital. Financialisation has introduced uncertainty in the commi... more

Download (352)

View PDF (165)

Global Fund Board discusses the lessons learned from the Seventh Replenishment and the action plan for the Eighth Replenishment

Independent Observer of Global Fund Aidspan (2023) CC

The Global Fund’s Board meeting on 14-16 November 2023 was its 50th; and among the many issues for information was on resource mobilization. The Board document provided an update on the status of the conversion of pledges and the signing of donor agreements. In addition, it presented the results... more

External Link

External Link (282)

How feasible is it to mobilize $31 billion a year for pandemic preparedness and response? An economic growth modelling analysis

Shahid M., Schäferhoff M., Brown G., et al. Globalization and Health (2024) CC

Covid-19 has reinforced health and economic cases for investing in pandemic preparedness and response (PPR). The World Bank and World Health Organization (WHO) propose that low- and middle-income governments and donor countries should invest $31.1 billion each year for PPR. We analyse, based on the... more

Download (50)

View PDF (49)

Mathematical modelling of lenacapavir: landscaping review on impact and cost–effectiveness
recommended

World Health Organization WHO (2025) C_WHO

Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex E

External Link

External Link (59)

FGH 2023: Malaria

Institute for Health Metrics IHME (2024) CC

Trends in development assitance for health

Download (240)

View PDF (581)

Santé pour tous: transformer les économies pour offrir ce qui compte : rapport final du Conseil de l’OMS sur l’économie de la santé pour tous : résumé d’orientation

World Health Organisation (WHO) (2024) C_WHO

En mai 2023, la COVID-19 n’est peut-être plus classifiée en tant qu’urgence de santé publique d’envergure internationale mais nous ne devons pas ignorer les profonds problèmes structurels qu’elle a révélé dans notre économie. La santé est un droit humain fondamental et le temps est... more

Mathematical modelling of lenacapavir: landscaping review on impact and cost–effectiveness recommended

Mathematical modelling of lenacapavir: landscaping review on impact and cost–effectiveness
recommended